{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:48:55Z","timestamp":1790668135331,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jacl.2026.03.004","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T03:19:20Z","timestamp":1773458360000},"page":"1133-1143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparison of different \u201cfamilial chylomicronemia syndrome\u201d clinical diagnosis scoring systems in patients with persistent chylomicronemia"],"prefix":"10.1016","volume":"20","author":[{"given":"Diane","family":"Brisson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Larouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Laflamme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedmohammad","family":"Saadatagah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Bergeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christie M.","family":"Ballantyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5185-3666","authenticated-orcid":false,"given":"Daniel","family":"Gaudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jacl.2026.03.004_bib1","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1503\/cmaj.060963","article-title":"Hypertriglyceridemia: its etiology, effects and treatment","volume":"176","author":"Yuan","year":"2007","journal-title":"CMAJ"},{"issue":"1","key":"10.1016\/j.jacl.2026.03.004_bib2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12933-022-01525-5","article-title":"Elevated plasma triglyceride concentration and risk of adverse clinical outcomes in 1.5 million people: a CALIBER linked electronic health record study","volume":"21","author":"Patel","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jacl.2026.03.004_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2025.119146","article-title":"The vicious circle of chronic kidney disease and hypertriglyceridemia: what is first, the hen or the egg?","volume":"403","author":"Tramontano","year":"2025","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.jacl.2026.03.004_bib4","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3390\/jcm10040669","article-title":"Non-alcoholic fatty liver in patients with chylomicronemia","volume":"10","author":"Maltais","year":"2021","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.jacl.2026.03.004_bib5","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jacl.2025.03.012","article-title":"Recognition and management of persistent chylomicronemia: a joint expert clinical consensus by the National Lipid Association and the American Society for Preventive Cardiology","volume":"19","author":"Saadatagah","year":"2025","journal-title":"J Clin Lipidol"},{"issue":"3","key":"10.1016\/j.jacl.2026.03.004_bib6","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jacl.2025.02.008","article-title":"Epidemiology and longitudinal course of chylomicronemia: insights from NHANES and a large health care system","volume":"19","author":"Saadatagah","year":"2025","journal-title":"J Clin Lipidol"},{"issue":"2","key":"10.1016\/j.jacl.2026.03.004_bib7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/MED.0000000000000903","article-title":"An overview of persistent chylomicronemia: much more than meets the eye","volume":"32","author":"Larouche","year":"2025","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"3","key":"10.1016\/j.jacl.2026.03.004_bib8","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jacl.2025.03.013","article-title":"Familial chylomicronemia syndrome: an expert clinical review from the National Lipid Association","volume":"19","author":"Javed","year":"2025","journal-title":"J Clin Lipidol"},{"issue":"6","key":"10.1016\/j.jacl.2026.03.004_bib9","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrendo.2015.26","article-title":"Chylomicronaemia\u2013current diagnosis and future therapies","volume":"11","author":"Brahm","year":"2015","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"10.1016\/j.jacl.2026.03.004_bib10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/genes16010055","article-title":"Lipoprotein lipase: structure, function, and genetic variation","volume":"16","author":"Perera","year":"2025","journal-title":"Genes"},{"key":"10.1016\/j.jacl.2026.03.004_bib11","unstructured":"Jensen\u00a0E, Jones N, Rabe MA, et al. United States Census Bureau.\u00a0The chance that two people chosen at random are of different race or ethnicity groups has increased since 2010. Accessed October 7, 2025.\u00a0www.census.gov\/library\/stories\/2021\/08\/2020-united-states-population-more-racially-ethnically-diverse-than-2010.html."},{"issue":"6","key":"10.1016\/j.jacl.2026.03.004_bib12","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41431-021-01022-5","article-title":"A systematic review of geographical inequities for accessing clinical genomic and genetic services for non-cancer related rare disease","volume":"30","author":"Best","year":"2022","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jacl.2026.03.004_bib13","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.atherosclerosis.2023.06.301","article-title":"The smash program: an initiative for greater access to innovations for rare or severe hyperlipidemia","volume":"379","author":"Larouche","year":"2023","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1016\/j.jacl.2026.03.004_bib14","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1210\/jc.2005-0205","article-title":"Combination of circulating antilipoprotein lipase (Anti-LPL) antibody and heterozygous S172 fsX179 mutation of LPL gene leading to chronic hyperchylomicronemia","volume":"90","author":"Pruneta-Deloche","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jacl.2026.03.004_bib15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0021-9150(77)90141-1","article-title":"Inhibition of lipoprotein lipase activity by a monoclonal immunoglobulin in autoimmune hyperlipidemia","volume":"26","author":"Beaumont","year":"1977","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1016\/j.jacl.2026.03.004_bib16","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1194\/jlr.R120001116","article-title":"Chylomicronemia from GPIHBP1 autoantibodies","volume":"61","author":"Miyashita","year":"2020","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2026.03.004_bib17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.clinbiochem.2023.02.002","article-title":"Correlation between chylomicronemia diagnosis scores and post-heparin lipoprotein lipase activity","volume":"114","author":"Brisson","year":"2023","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jacl.2026.03.004_bib18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.atherosclerosis.2018.06.814","article-title":"Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel re--ations and proposal of an \"FCS score\"","volume":"275","author":"Moulin","year":"2018","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.jacl.2026.03.004_bib19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jacl.2024.09.008","article-title":"Development and validation of clinical criteria to identify familial chylomicronemia syndrome (FCS) in North America","volume":"19","author":"Hegele","year":"2025","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2026.03.004_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2025.100978","article-title":"Recognition and management of persistent chylomicronemia: a\u00a0joint expert clinical consensus by the National Lipid Association and the American Society for Preventive Cardiology","volume":"22","author":"Saadatagah","year":"2025","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.jacl.2026.03.004_bib21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1034\/j.1399-0004.1999.550408.x","article-title":"Procedure to protect confidentiality of familial data in community genetics and genomic research","volume":"55","author":"Gaudet","year":"1999","journal-title":"Clin Genet"},{"issue":"2","key":"10.1016\/j.jacl.2026.03.004_bib22","first-page":"61","article-title":"Les dyslipoprot\u00e9in\u00e9mies au Qu\u00e9bec: le d\u00e9ficit primaire en lipase lipoprot\u00e9ique et l'hypercholest\u00e9rol\u00e9mie familiale [Dyslipoproteinemias in Quebec: primary deficit in lipoprotein lipase and familial hypercholesterolemia]","volume":"124","author":"Gagn\u00e9","year":"1995","journal-title":"Union Med Can"},{"issue":"1","key":"10.1016\/j.jacl.2026.03.004_bib23","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12944-020-01302-x","article-title":"The burden of familial chylomicronemia syndrome in Canadian patients","volume":"19","author":"Gaudet","year":"2020","journal-title":"Lipids Health Dis"},{"issue":"1","key":"10.1016\/j.jacl.2026.03.004_bib24","first-page":"29","article-title":"Genealogy and regional distribution of lipoprotein lipase deficiency in French-Canadians of Quebec","volume":"65","author":"Dionne","year":"1993","journal-title":"Hum Biol"},{"key":"10.1016\/j.jacl.2026.03.004_bib25","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/hmg\/1.7.541","article-title":"Mismatch PCR: a rapid method to screen for the Pro207-->Leu mutation in the lipoprotein lipase (LPL) gene","volume":"1","author":"Bijvoet","year":"1992","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jacl.2026.03.004_bib26","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1172\/JCI114769","article-title":"A missense mutation at codon 188 of the human lipoprotein lipase gene is a frequent cause of lipoprotein lipase deficiency in persons of different ancestries","volume":"86","author":"Monsalve","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2026.03.004_bib27","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2362.1996.tb02146.x","article-title":"Lipoprotein lipase gene mutations D9N and N291S in four pedigrees with familial combined hyperlipidaemia","volume":"26","author":"de Bruin","year":"1996","journal-title":"Eur J Clin Invest"},{"issue":"12","key":"10.1016\/j.jacl.2026.03.004_bib28","first-page":"5463","article-title":"DNA sequencing with chain-terminating inhibitors","volume":"74","author":"Sanger","year":"1977","journal-title":"Proc\u00a0Natl Acad\u00a0Sci\u00a0USA"},{"issue":"1","key":"10.1016\/j.jacl.2026.03.004_bib29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/genes16010055","article-title":"Lipoprotein lipase: structure, function, and genetic variation","volume":"16","author":"Perera","year":"2025","journal-title":"Genes"},{"key":"10.1016\/j.jacl.2026.03.004_bib30","first-page":"E107","article-title":"Human adipose tissue lipoprotein lipase: changes with feeding and relation to postheparin plasma","volume":"249","author":"Iverius","year":"1985","journal-title":"Am J Physiol"},{"issue":"11","key":"10.1016\/j.jacl.2026.03.004_bib31","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.21037\/tp-22-515","article-title":"Familial chylomicronemia syndrome in children: a diagnosis challenge","volume":"11","author":"Ariza","year":"2022","journal-title":"Transl Pediatr"},{"issue":"1","key":"10.1016\/j.jacl.2026.03.004_bib32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11883-025-01295-x","article-title":"Novel therapeutics for familial chylomicronemia syndrome","volume":"27","author":"Izar","year":"2025","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jacl.2026.03.004_bib33","unstructured":"Canada\u2019s Drug Agency. Olezarsen (Tryngolza). Reimbursement Re--ation. Accessed January 30, 2025. https:\/\/www.cda-amc.ca\/fr\/olezarsen."},{"key":"10.1016\/j.jacl.2026.03.004_bib34","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/91060","article-title":"The value of isolated populations","volume":"28","author":"Shifman","year":"2001","journal-title":"Nat Genet"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287426000723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287426000723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:50:48Z","timestamp":1785880248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287426000723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1933287426000723"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2026.03.004","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of different \u201cfamilial chylomicronemia syndrome\u201d clinical diagnosis scoring systems in patients with persistent chylomicronemia","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2026.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of National Lipid Association.","name":"copyright","label":"Copyright"}]}}